Cognizant to apply generative AI to enhance drug discovery for pharmaceutical clients with NVIDIA BioNeMo
07.08.2025 - 18:08:49Cognizant to apply generative AI to enhance drug discovery for pharmaceutical clients with NVIDIA BioNeMo. Cognizant Benin Burkina Faso Burundi Cameroon Chad Comoros Cote d'Ivoire Djibouti Ethiopia Gabon Gambia Ghana Guinea Equatorial Guinea Kenya Liberia Madagascar Mali Namibia Niger Nigeria Central African Republic Congo, The Democratic Republic of the Congo, The Republic of the Senegal Sierra Leone South Africa Sudan Tanzania Tonga Uganda Zambia Zimbabwe Algeria Angola Botswana Cape Verde Egypt Eritrea Guinea-Bissau Lesotho Libya Malawi Mauritania Mauritius Morocco Mozambique Rwanda Sao Tome and Principe Seychelles South Sudan Swaziland Togo Tunisia New Jersey
For more information, contact:
U.S.
Name Ben Gorelick
Email
benjamin.gorelick@cognizant.com
Europe / APAC
Name Christina Schneider
Email
christina.schneider@cognizant.com
India
Name Rashmi Vasisht
Email
rashmi.vasisht@cognizant.com
Logo - https://mma.prnewswire.com/media/1794711/Cognizant_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/cognizant-to-apply-generative-ai-to-enhance-drug-discovery-for-pharmaceutical-clients-with-nvidia-bionemo-302092233.html

